Skip to main content
TruScreen Group Limited logo

TruScreen Group Limited — Investor Relations & Filings

Ticker · TRU ISIN · NZTRUE0001S7 NZX Manufacturing
Open in API
Filings indexed 366 across all filing types
Latest filing 2022-09-06 Declaration of Voting R…
Country NZ New Zealand
Listing NZX TRU

About TruScreen Group Limited

https://www.truscreen.com

TruScreen Group Limited develops and manufactures a proprietary cervical cancer screening system that utilizes opto-electrical technology for the real-time detection of precancerous and cancerous tissue. The system employs a single-use sensor to measure tissue response to specific electrical and optical stimuli, processing the data through an integrated algorithm to provide an immediate objective result. By eliminating the requirement for laboratory processing, tissue sampling, and specialized pathology infrastructure, the technology facilitates point-of-care screening in diverse clinical environments. The device is designed to address the limitations of traditional cytology, offering a non-invasive, portable solution that enhances the efficiency of screening programs and improves patient access to diagnostic results.

Recent filings

Filing Released Lang Actions
Shareholder Meeting Results
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled 'RESULTS OF ANNUAL MEETING' and contains detailed voting results for resolutions proposed at the Annual Meeting of TRUSCREEN GROUP LIMITED held on 6 September 2022. It includes vote counts for and against various resolutions, including board member re-election and auditor remuneration. The content is focused on the official results of shareholder votes at the meeting, not the meeting materials or presentations themselves. The document length is short (1775 characters), but it contains substantive voting results, not just an announcement that results are available elsewhere. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-09-06 English
Annual Meeting Presentation
Regulatory Filings
2022-09-06 English
TRU Signs Five Year Manufacturing Agreement for SUS Supply
Capital/Financing Update Classification · 95% confidence The document is an announcement dated 1 September 2022 from TruScreen Group Limited regarding a five-year manufacturing agreement with Zapco International Limited for the supply of Single Use Sensors (SUS). The content focuses on the contract details, strategic supplier relationship, and expected benefits to the company's financial performance. There are no financial statements, quarterly or annual results, nor any regulatory filings or voting results. The document is a corporate announcement about a supply contract, which fits best under Capital/Financing Update (CAP) as it relates to a significant supply agreement impacting the company's operations and cost structure. The document length is 4269 characters, which is short but contains substantive information about the contract rather than just a brief notice or report publication announcement. Therefore, the most appropriate classification is CAP with high confidence.
2022-08-31 English
Director and Officer Disclosure Notice
Director's Dealing Classification · 100% confidence The document is a disclosure notice regarding the acquisition and disposal of relevant interests in the company's shares by a director or senior manager, specifically Anthony Ho. It details the number of shares held before and after the transaction, the nature of the transaction (on-market purchase), the consideration paid, and other relevant interests including unlisted options. The document references sections of the Financial Markets Conduct Act 2013, indicating regulatory compliance for insider trading disclosures. It includes certification by an authorized person but does not contain financial statements, earnings data, or management discussion. This type of document is a report of personal share transactions by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length and content confirm it is not a brief announcement or a regulatory filing fallback but a specific insider trading disclosure.
2022-08-14 English
Relaunch of TruScreen Devices in Xinjiang Uygur Region
Capital/Financing Update Classification · 85% confidence The document is an announcement dated 10 August 2022 from TruScreen Group Limited regarding the relaunch of distribution of their cervical cancer screening device in the Xinjiang Uygur Autonomous Region of China. It highlights key business developments such as delivery of devices and strategic manufacturing decisions. There are no financial statements, regulatory certifications, voting results, or detailed financial data. The content is a business update about product distribution and market activity rather than a financial report or regulatory filing. The document is relatively short (4683 characters) and reads as a market announcement or business update. Therefore, it fits best under the category of Capital/Financing Update (CAP), which includes updates on company fundraising, financing activities, or capital structure changes, but also broadly covers significant business operational updates like distribution relaunches and market expansion announcements.
2022-08-10 English
TruScreen Cervical Cancer Screening Centre Mexico City
Regulatory Filings Classification · 95% confidence The document is an announcement dated 3 August 2022 from TruScreen Group Limited regarding the opening of a TruScreen-based cervical cancer screening centre in Mexico City. It highlights the partnership with Mexpharm Medical Clinical, the market potential in Mexico, and the company's technology. The content is promotional and informative about business expansion and product deployment rather than financial results, regulatory filings, or management changes. There are no financial statements, earnings data, or regulatory compliance details. The document is a corporate announcement about a business development and market expansion, not a financial report or regulatory filing. Therefore, it fits best under the category of a general Regulatory Filing (RNS) as it is a regulatory announcement that does not fit into more specific categories like earnings release, capital update, or management changes.
2022-08-03 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.